PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New drug improves survival in multiple myeloma relapse, Moffitt Cancer Center researchers say

Pomalidomide found safe and efficacious; extends overall survival for those failing other drugs

2013-01-24
(Press-News.org) Researchers at Moffitt Cancer Center and colleagues have investigated the safety, efficacy and the maximum tolerated dose of pomalidomide for patients with multiple myeloma who have disease relapsed after treatments with other drugs, such as bortezomib and lenalidomide. This phase I clinical trial enrolled 38 patients, and pomalidomide provided a minimal or better response for 42 percent of the patients, a partial response or better for 21 percent, and a complete response for 3 percent.

The study, a collaborative effort among researchers from Moffitt, Dana-Farber Cancer Institute, Hackensack University Medical Center, Multiple Myeloma Research Consortium, and Celgene Corporation, appeared in the Dec. 14 issue of Blood, the journal of the American Society of Hematology.

According to the authors, almost all multiple myeloma patients treated with bortezomib, lenalidomide or thalidomide relapse, and survival times shorten progressively with each subsequent relapse. Effective new treatments that re-establish tumor response are urgently required to improve outcomes for these patients.

"This open-label, phase I, dose-escalation study was primarily conducted to evaluate the maximum tolerated dose of pomalidomide," said study co-author Daniel Sullivan, M.D., associate center director for clinical investigations at Moffitt. "The secondary objective was to assess safety of pomalidomide when given with or without dexamethasone."

The researchers found that pomalidomide, given in escalating doses (from 2 to 5 mg per day for 21 of 28 days) in combination with low doses of dexamethasone, demonstrated "encouraging activity with manageable toxicity." The researchers noted that there was a low incidence of peripheral neuropathy in their study patients, all of whom had eventually failed past treatment with drugs known to be associated with neurotoxicity. Common adverse events included neutropenia, anemia, thrombocytopenia and fatigue. These adverse events were generally manageable and are not unexpected in this clinical situation.

Ongoing phase II studies have confirmed the safety and efficacy of this drug in patients with relapsed myeloma. The Food and Drug Administration is considering the drug for approval for this patient population.

###

Melissa Alsina, M.D., and Rachid Baz, M.D., both associate members of the Experimental Therapeutics Program at Moffitt, worked with Sullivan on this study.

About Moffitt Cancer Center

Located in Tampa, Moffitt is one of only 41 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt's excellence in research, its contributions to clinical trials, prevention and cancer control. Since 1999, Moffitt has been listed in U.S. News & World Report as one of "America's Best Hospitals" for cancer. With more than 4,200 employees, Moffitt has an economic impact on the state of nearly $2 billion. For more information, visit MOFFITT.org, and follow the Moffitt momentum on Facebook, twitter and YouTube.

Media release by Florida Science Communications

END



ELSE PRESS RELEASES FROM THIS DATE:

Using Social Media To Search For Sex Offenders

2013-01-24
Using social media to search for sex offenders Facebook and other social media sites have been increasing their efforts to identify possible child predators that use their sites to reach children and teenagers. While the technology available to Facebook has improved and expanded over time, most online predators are not flagged in the system and end up reaching their victims without ever being stopped or identified. While some arrests are being made through the efforts of these websites, they still face problems trying to make sure that their sites aren't being used to ...

Concussions More Harmful Than Thought, Symptoms Persist for Years

2013-01-24
Concussions More Harmful Than Thought, Symptoms Persist for Years For years physicians, coaches and parents thought that a concussion was something that could be cured with a little rest. Unfortunately, new research is questioning this notion. Researchers with the University of Oklahoma suggest that the symptoms associated with concussions, also known as traumatic brain injuries, can last years longer than expected. Even more surprising: the symptoms may not decrease in intensity. Details of the Study The study focused on the severity and duration of symptoms ...

New Law Increases Penalty For Fatal Hit-and-Run Accidents

2013-01-24
New law increases penalty for fatal hit-and-run accidents Leaving the scene of an accident has always been a serious offense. Now, drivers who flee the scene in Pennsylvania face even tougher penalties under a law designed to punish drivers involved in fatal hit-and-run accidents. Details of the new law A fatal accident in 2005, involving a 29-year-old man who was hit while riding his bicycle by a driver who fled the scene, prompted the new law, which went into effect in September 2012. Previously classified as a third-degree felony, fatal hit-and-runs carried ...

Child Custody Involving Grandparents

2013-01-24
Child custody involving grandparents While grandparents can have a large and important role in a child's life, they do not have a constitutional right to see their grandchildren. The Supreme Court case Troxel v. Granville decided that parents are the individuals with the "fundamental right" to make decisions about the care of their children. Grandparents do not have the same legal rights over the care of their grandchildren, and their rights are limited in comparison to those of a parent. However a lack of a constitutional right to visitation does not mean ...

How Small Businesses Can Handle Tax Audits

2013-01-24
How small businesses can handle tax audits You do not have to run an unethical small business in order to be the subject of an audit by the Internal Revenue Service. And even if you have not done anything wrong, that does not make the process any less stressful. The following tips can help you avoid a tax audit, as well as help to deal with the IRS if your business is being audited. How to avoid a tax audit Although you may not be intentionally trying to defraud the government when you file your taxes, there are some common mistakes that small businesses make that ...

Lawsuit Accuses Video Game Demonstration Company of Age Discrimination

2013-01-24
Lawsuit Accuses Video Game Demonstration Company of Age Discrimination It is no secret that video games have become popular with people of all ages - whether on a phone, console, or personal computer, video games have become a popular pastime. Nevertheless, despite the acknowledged cross-generational appeal of video games, one video game marketing company has been accused of age discrimination. According to a lawsuit recently filed in Missouri, Mosaic Sales Solutions US Operating Company - a company that demonstrates Microsoft video game products - requires all job ...

Researchers develop new methods for diagnosing TBI

2013-01-24
Researchers develop new methods for diagnosing TBI Traumatic brain injuries are some of the most devastating injuries that can be suffered in a car crash or other accident. Even a minor brain injury can cause severe pain and short-term sensory and cognitive difficulties. More serious brain injuries can have life-long consequences. Many TBI victims experience severe and persistent headaches. Cognitive problems are also common, including slowed thinking, forgetfulness and trouble with decision making. In addition, many TBI victims experience changes in personality and ...

Halcyon Days Ahead For SASIT Customers

2013-01-24
Halcyon Software, a leading global provider of monitoring, scheduling and automation software, has signed a reseller agreement with SASIT, the Auckland-based Managed Services Provider, to become its first business partner in New Zealand. As sole national reseller, SASIT will provide customers using the IBM i series with access to Halcyon's full range of solutions. SASIT has been using Halcyon products to manage its own IBM Power Systems running the IBM i operating system since 2011. The company began evaluating systems management products two years ago as significant ...

Gary Novack of PharmaLogic to Speak at 5th Ocular Diseases Conference March 2013

2013-01-24
Gary Novack, President at PharmaLogic Development will give a featured presentation on "Thirty Years of Developing New Therapeutic Ophthalmic Drugs - Some Simple Principles" at GTC's 5th Ocular Diseases and Drug Development Conference to be held in San Francisco, CA on March 21-22, 2013. Gary has been involved in the development of scores of ophthalmic products for over 30 years. In his presentation, he will present a brief list of basic principles of pharmacology, the scientific method, and communication and their application to ophthalmic product development. ...

Design Custom Soccer Uniforms for Teams and Clubs with Mysocceruniform

2013-01-24
Mysocceruniform.com have had a huge impact of the custom made sports uniform market is United States and are now going full steam ahead into Soccer Uniforms and Soccer Jerseys. We are designing custom made your Soccer uniforms to match your club colours, design etc. Design tool is available on the site to design your own custom made soccer uniforms and semi custom soccer uniforms. With design tool your next soccer uniform can be design quickly and to your liking. You can not only make custom soccer jerseys but you can also make Soccer Shorts, Soccer socks, women soccer ...

LAST 30 PRESS RELEASES:

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

[Press-News.org] New drug improves survival in multiple myeloma relapse, Moffitt Cancer Center researchers say
Pomalidomide found safe and efficacious; extends overall survival for those failing other drugs